|

LY4064809 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: STX-478, Tersolisib

Pipeline

Phase 3: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Neoplasm Metastasis1
  • Breast Neoplasms1
  • Breast Cancer1
  • Cancer1

Anchorage, Alaska1 trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Alaska Oncology and Hematology

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.